These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

212 related items for PubMed ID: 36169661

  • 1. Neuroblastoma Suppressor of Tumorigenicity 1 Mediates Endothelial-to-Mesenchymal Transition in Pulmonary Arterial Hypertension Related to Congenital Heart Disease.
    Wen B, Peng R, Kong P, Li Z, Liu Y, Ouyang W, Xie Y, Hu X, Wang Q, Pan X.
    Am J Respir Cell Mol Biol; 2022 Dec; 67(6):666-679. PubMed ID: 36169661
    [Abstract] [Full Text] [Related]

  • 2. miR-27a promotes endothelial-mesenchymal transition in hypoxia-induced pulmonary arterial hypertension by suppressing BMP signaling.
    Liu T, Zou XZ, Huang N, Ge XY, Yao MZ, Liu H, Zhang Z, Hu CP.
    Life Sci; 2019 Jun 15; 227():64-73. PubMed ID: 31004656
    [Abstract] [Full Text] [Related]

  • 3. miR-181b-5p inhibits endothelial-mesenchymal transition in monocrotaline-induced pulmonary arterial hypertension by targeting endocan and TGFBR1.
    Zhao H, Wang Y, Zhang X, Guo Y, Wang X.
    Toxicol Appl Pharmacol; 2020 Jan 01; 386():114827. PubMed ID: 31734320
    [Abstract] [Full Text] [Related]

  • 4. Mechanical strain triggers endothelial-to-mesenchymal transition of the endocardium in the immature heart.
    Vorisek C, Weixler V, Dominguez M, Axt-Fliedner R, Hammer PE, Lin RZ, Melero-Martin JM, Del Nido PJ, Friehs I.
    Pediatr Res; 2022 Sep 01; 92(3):721-728. PubMed ID: 34837068
    [Abstract] [Full Text] [Related]

  • 5. Nestin represents a potential marker of pulmonary vascular remodeling in pulmonary arterial hypertension associated with congenital heart disease.
    Zhou JJ, Li H, Qian YL, Quan RL, Chen XX, Li L, Li Y, Wang PH, Meng XM, Jing XL, He JG.
    J Mol Cell Cardiol; 2020 Dec 01; 149():41-53. PubMed ID: 32950539
    [Abstract] [Full Text] [Related]

  • 6. Exacerbated inflammatory signaling underlies aberrant response to BMP9 in pulmonary arterial hypertension lung endothelial cells.
    Szulcek R, Sanchez-Duffhues G, Rol N, Pan X, Tsonaka R, Dickhoff C, Yung LM, Manz XD, Kurakula K, Kiełbasa SM, Mei H, Timens W, Yu PB, Bogaard HJ, Goumans MJ.
    Angiogenesis; 2020 Nov 01; 23(4):699-714. PubMed ID: 32813135
    [Abstract] [Full Text] [Related]

  • 7. Endothelial-to-Mesenchymal Transition in Pulmonary Arterial Hypertension.
    Gorelova A, Berman M, Al Ghouleh I.
    Antioxid Redox Signal; 2021 Apr 20; 34(12):891-914. PubMed ID: 32746619
    [Abstract] [Full Text] [Related]

  • 8. Gremlin-1 is a key regulator of endothelial-to-mesenchymal transition in human pulmonary artery endothelial cells.
    Zhang Y, Zhang M, Xie W, Wan J, Tao X, Liu M, Zhen Y, Lin F, Wu B, Zhai Z, Wang C.
    Exp Cell Res; 2020 May 01; 390(1):111941. PubMed ID: 32145252
    [Abstract] [Full Text] [Related]

  • 9. Curcumol suppresses endothelial-to-mesenchymal transition via inhibiting the AKT/GSK3β signaling pathway and alleviates pulmonary arterial hypertension in rats.
    Nie X, Wu Z, Shang J, Zhu L, Liu Y, Qi Y.
    Eur J Pharmacol; 2023 Mar 15; 943():175546. PubMed ID: 36706802
    [Abstract] [Full Text] [Related]

  • 10. MED1 Regulates BMP/TGF-β in Endothelium: Implication for Pulmonary Hypertension.
    Wang C, Xing Y, Zhang J, He M, Dong J, Chen S, Wu H, Huang HY, Chou CH, Bai L, He F, She J, Su A, Wang Y, Thistlethwaite PA, Huang HD, Yuan JX, Yuan ZY, Shyy JY.
    Circ Res; 2022 Oct 28; 131(10):828-841. PubMed ID: 36252121
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Tenascin-X Mediates Flow-Induced Suppression of EndMT and Atherosclerosis.
    Liang G, Wang S, Shao J, Jin YJ, Xu L, Yan Y, Günther S, Wang L, Offermanns S.
    Circ Res; 2022 May 27; 130(11):1647-1659. PubMed ID: 35443807
    [Abstract] [Full Text] [Related]

  • 13. Twist1 in Hypoxia-induced Pulmonary Hypertension through Transforming Growth Factor-β-Smad Signaling.
    Mammoto T, Muyleart M, Konduri GG, Mammoto A.
    Am J Respir Cell Mol Biol; 2018 Feb 27; 58(2):194-207. PubMed ID: 28915063
    [Abstract] [Full Text] [Related]

  • 14. Protective effect of hydrogen sulfide on monocrotaline‑induced pulmonary arterial hypertension via inhibition of the endothelial mesenchymal transition.
    Zhang H, Lin Y, Ma Y, Zhang J, Wang C, Zhang H.
    Int J Mol Med; 2019 Dec 27; 44(6):2091-2102. PubMed ID: 31573044
    [Abstract] [Full Text] [Related]

  • 15. Structure of neuroblastoma suppressor of tumorigenicity 1 (NBL1): insights for the functional variability across bone morphogenetic protein (BMP) antagonists.
    Nolan K, Kattamuri C, Luedeke DM, Angerman EB, Rankin SA, Stevens ML, Zorn AM, Thompson TB.
    J Biol Chem; 2015 Feb 20; 290(8):4759-4771. PubMed ID: 25561725
    [Abstract] [Full Text] [Related]

  • 16. N6-methyladenosine modification of KLF2 may contribute to endothelial-to-mesenchymal transition in pulmonary hypertension.
    Kang K, Xiang J, Zhang X, Xie Y, Zhou M, Zeng L, Zhuang J, Kuang J, Lin Y, Hu B, Xiong Q, Yin Q, Su Q, Liao X, Wang J, Niu Y, Liu C, Tian J, Gou D.
    Cell Mol Biol Lett; 2024 May 13; 29(1):69. PubMed ID: 38741032
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. TGF-β1-induced SMAD2/3/4 activation promotes RELM-β transcription to modulate the endothelium-mesenchymal transition in human endothelial cells.
    Jiang Y, Zhou X, Hu R, Dai A.
    Int J Biochem Cell Biol; 2018 Dec 13; 105():52-60. PubMed ID: 30120989
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.